Letter: Risk Prediction Model for HCC in Subjects Without Apparent Chronic Liver Disease: A Dilemma in Asia. Author's Reply

Documenti analoghi

• Risk Prediction Model for HCC in Subjects Without Apparent Chronic Liver Disease: A Dilemma in Asia
  di: Teh‐Ia Huo, et al.
  Pubblicazione: (2025)
• Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C
  di: Yu Rim Lee, et al.
  Pubblicazione: (2025)
• Letter to the Editor Regarding “Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C”
  di: Tiancheng Gong
  Pubblicazione: (2025)
• Comparative Validation of Prediction Models for HCC Outcomes in Living Donor Liver Transplantation: Superiority of Tumor Markers to Imaging Study
  di: Hwa‐Hee Koh, et al.
  Pubblicazione: (2024)
• Reply Letter to: A Critical Assessment of “Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis”
  di: Mi Na Kim
  Pubblicazione: (2026)